Categories: Research

Shu receives NIH New Innovator Award to study protein interactions

Xiaokun Shu, PhD, has been named a recipient of the 2012 National Institutes of Health (NIH) Director’s New Innovator award, which will provide up to $1.5 million in research funding over the next five

Study finds new role in cell division for well-known transport protein

New research has found that the protein clathrin, well known as a building block of containers used to transport biological cargo inside cells, also plays a key role in helping cells divide properly.

Conflicts of interest significantly underreported in systematic reviews of drug efficacy, safety

Systematic reviews seek to answer key questions about the relative effectiveness and safety of medical interventions by selecting, combining, and critically evaluating the research in published medical literature.

Master of Translational Medicine program gets final UC approval

Two years after launching as a pilot effort, an innovative graduate curriculum in translational medicine jointly offered by UCSF and UC Berkeley has received final approval from University of California President Mark Yudof as a master’s degree program.

Child’s illness fuels lab team’s search for early-life epilepsy diagnostics

The lab of UCSF School of Pharmacy faculty member Nadav Ahituv, PhD, studies how abnormalities in DNA segments that control the activity of genes could lead to diseases.

Computer models successfully predict drug side effects

New computer models were able to successfully predict negative side effects for hundreds of currently marketed drugs, report researchers from the UCSF School of Pharmacy, SeaChange Pharmaceuticals, and Novartis Institutes for Biomedical Research in

Teaching old drugs new tricks at the Small Molecule Discovery Center: arthritis drug could treat dysentery

The UCSF School of Pharmacy’s Small Molecule Discovery Center (SMDC) provided a key assist to researchers seeking to repurpose existing drugs to treat the worldwide scourge of amoebic dysentery.

The Lancet profiles Lisa Bero’s “path of most resistance”

Health policy expert Lisa Bero, PhD, is hailed in the latest issue of The Lancet for tackling hot-button subjects such as financial biases in drug research.

Cancer drug dosing in kids, medication-related delirium, and battery swallowing take top honors at seminar

Studies of cancer drug dosing in children, possible medication links to delirium in hospital patients, and how to decide when swallowed batteries may call for invasive removal took top honors at the Department of Clinical Pharmacy’s 14th annual Spring Research Seminar.

Self care group supports researching non-prescription access by patients to urgent and chronic care drugs

On March 22 and 23, 2012, the U.S. Food and Drug Administration (FDA) held a public hearing to explore the idea of switching some medications to treat chronic conditions and health emergencies from prescription to over- and behind-the-counter status.

Pages